Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

Benchmarks of meaningful impairment on the MSFC and BICAMS

(2016) Ralph HB Benedict et al.   Multiple Sclerosis Journal

Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic

(2016) Francois A. Bethoux et al.   INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH

Benchmarks of meaningful impairment on the MSFC and BICAMS

(2016) Ralph HB Benedict et al.   Multiple Sclerosis Journal

Exercise as a Therapy for Improvement of Walking Ability in Adults With Multiple Sclerosis: A Meta-Analysis

(2015) Melissa Pearson et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis

(2015) Brian M. Sandroff et al.   GAIT & POSTURE

Relationships Among Physical Inactivity, Deconditioning, and Walking Impairment in Persons With Multiple Sclerosis

(2015) Brian M. Sandroff et al.   Journal of Neurologic Physical Therapy

Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis

(2015) Robert W. Motl et al.   BMC Geriatrics

Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment

(2014) HB Jensen et al.   Multiple Sclerosis Journal

The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis

(2014) Jeffrey A. Cohen et al.   JAMA Neurology

Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis

(2013) Yvonne C Learmonth et al.   BMC Neurology

Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores

(2013) Robert W. Motl et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses

(2013) Petar Filipović Grčić et al.   MEDICAL SCIENCE MONITOR

The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis

(2013) Yvonne C Learmonth et al.   Multiple Sclerosis Journal

Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world

(2013) M. D. Goldman et al.   NEUROLOGY

Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS

(2013) J. Hobart et al.   NEUROLOGY

Ambulation and Multiple Sclerosis

(2013) Robert W. Motl   Physical Medicine and Rehabilitation Clinics of North America

Ambulatory Activity in Individuals With Multiple Sclerosis

(2013) James T. Cavanaugh et al.   Journal of Neurologic Physical Therapy

Accelerometry as a measure of walking behavior in multiple sclerosis

(2012) R. W. Motl et al.   ACTA NEUROLOGICA SCANDINAVICA

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

(2012) Jeffrey A Cohen et al.   LANCET NEUROLOGY

Assessing walking disability in multiple sclerosis

(2012) Bernd C. Kieseier et al.   Multiple Sclerosis Journal

Reliability and clinical significance of mobility and balance assessments in multiple sclerosis

(2012) Yvonne C. Learmonth et al.   INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis

(2011) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Quantifying gait impairment in multiple sclerosis using GAITRite™ technology

(2011) Jacob J. Sosnoff et al.   GAIT & POSTURE

Upper and Lower Extremity Motor Function and Cognitive Impairment in Multiple Sclerosis

(2011) Ralph H.B. Benedict et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Effect of time of day on walking capacity and self-reported fatigue in persons with multiple sclerosis: a multi-center trial

(2011) P Feys et al.   Multiple Sclerosis Journal

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

Accelerometry and Its Association With Objective Markers of Walking Limitations in Ambulatory Adults With Multiple Sclerosis

(2010) Robert W. Motl et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Possible clinical outcome measures for clinical trials in patients with multiple sclerosis

(2010) Myla D. Goldman et al.   Therapeutic Advances in Neurological Disorders

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

(2008) C Heesen et al.   Multiple Sclerosis Journal

Dose comparison trial of sustained-release fampridine in multiple sclerosis

(2008) A. D. Goodman et al.   NEUROLOGY

Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls

(2007) Myla D Goldman et al.   Multiple Sclerosis Journal